These results imply that SE can mitigate cognitive impairment through the attenuation of colitis and neuroinflammation by inhibiting NF-κB signaling, in particular the suppression of pro-inflammatory cytokines to anti-inflammatory cytokine expression ratio. This evidence concerns the gene NFKB1 and colitis.